Earnings History Data for Apellis Pharmaceuticals, Inc. (APLS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Apellis Pharmaceuticals, Inc. is based in CRESTWOOD, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-02-2024 PM APLS Apellis Pharmaceuticals, Inc. 8,110 -0.73 -0.66 -1.50 Apellis Pharmaceuticals GAAP EPS of -$0.73 misses by $0.04, revenue of $146.4M beats by $2.81M
[2/27/2024 7:06 AM]
69.39 -2.34 
(-3.26%)
69.00 -2.73 
(-3.81%)
19.83 - 94.75 2,256,136 1,080,000 20,112
01-11-2023 PM APLS Apellis Pharmaceuticals, Inc. 5,640 -1.17 -0.86 -1.75 Apellis Pharmaceuticals GAAP EPS of -$1.17 misses by $0.31, revenue of $110.4M beats by $11.67M
[11/1/2023 7:10 AM]
49.92 1.27 
(2.60%)
46.02 -2.64 
(-5.43%)
19.83 - 94.75 2,590,741 1,550,000 152,422
31-07-2023 PM APLS Apellis Pharmaceuticals, Inc. 3,740 -1.02 -1.35 -1.46 Apellis Pharmaceuticals GAAP EPS of -$1.02 beats by $0.30, revenue of $94.9M beats by $23.78M
[7/31/2023 7:07 AM]
25.68 -6.34 
(-19.80%)
31.17 -0.85 
(-2.65%)
24.97 - 94.75 18,413,652 10,890,000 1,933,764
04-05-2023 AH 4:05 PM ET
(May 4)
APLS Apellis Pharmaceuticals, Inc. 9,660 -1.56 -1.42 -1.42 Apellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74M
[5/4/2023 4:45 PM]
93.03 8.66 
(10.26%)
92.25 7.88 
(9.34%)
33.32 - 94.45 3,774,072 1,850,000 45,917
21-02-2023 AH 4:05 PM ET
(Feb 21)
APLS Apellis Pharmaceuticals 6,136 -1.50 -1.65 0.00 Apellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86M
[2/21/2023 4:57 PM]
66.25 7.75 
(13.25%)
61.00 2.50 
(4.27%)
33.32 - 70.00 4,682,521 1,930,000 49,510
07-11-2022 AH 4:05 PM ET
(Nov 7)
APLS Apellis Pharmaceuticals, Inc. 6,600 -1.75 -1.48 -2.28 Apellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46M
[11/7/2022 4:24 PM]
47.24 -0.38 
(-0.80%)
48.10 0.48 
(1.01%)
33.08 - 70.00 2,455,114 1,790,000 66,894
08-08-2022 AH 4:05 PM ET
(Aug 8)
APLS Apellis Pharmaceuticals, Inc. 5,620 -1.46 -1.43 -2.72 Apellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63M
[8/8/2022 4:15 PM]
64.25 1.92 
(3.08%)
59.01 -3.32 
(-5.33%)
27.50 - 67.74 878,629 1,240,000 1,678
04-05-2022 AH 4:05 PM ET
(May 4)
APLS Apellis Pharmaceuticals 4,635 -1.42 -1.36 0.00 Apellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52M
[5/4/2022 4:13 PM]
44.43 -1.52 
(-3.31%)
41.36 -4.59 
(-9.99%)
27.50 - 73.00 727,856 930,000 8,203
28-02-2022 AH 4:00 PM ET
(Feb 28)
APLS Apellis Pharmaceuticals, Inc. 4,220 -1.61 -1.32 0.93 Apellis Pharmaceuticals GAAP EPS of -$1.61 misses by $0.12, revenue of $60.29M beats by $51.51M
[2/28/2022 4:31 PM]
44.64 2.11 
(4.96%)
42.53 0.0 
(0.00%)
27.50 - 73.00 1,184,474 680,000 12,360
08-11-2021 AH 4:00 PM ET
(Nov 8)
APLS Apellis Pharmaceuticals, Inc. 2,990 -2.28 -1.73 -1.79 Apellis Pharmaceuticals EPS misses by $0.57, misses on revenue
[11/8/2021 4:04 PM]
37.36 3.67 
(10.89%)
33.00 -0.69 
(-2.05%)
27.50 - 73.00 1,990,143 880,000 85,601
09-08-2021 AH 4:00 PM ET
(Aug 9)
APLS Apellis Pharmaceuticals, Inc. 5,590 -2.72 -1.70 -1.57 Apellis Pharmaceuticals EPS misses by $1.03, beats on revenue
[8/9/2021 4:19 PM]
59.90 -2.10 
(-3.40%)
62.00 0.0 
(0.00%)
26.38 - 73.00 615,635 720,000 196,848
28-04-2021 AH 4:00 PM ET
(Apr 28)
APLS Apellis Pharmaceuticals, Inc. 3,630 -2.32 -1.69 -2.29 Apellis Pharmaceuticals EPS misses by $0.69
[4/28/2021 4:03 PM]
48.39 3.09 
(6.82%)
45.30 0.0 
(0.00%)
25.49 - 58.47 721,832 580,000 9,920
25-02-2021 AH 4:10 PM ET
(Feb 25)
APLS Apellis Pharmaceuticals, Inc. 3,660 0.93 -0.47 -1.70 Apellis Pharmaceuticals EPS beats by $1.38, beats on revenue
[2/25/2021 4:02 PM]
48.37 3.32 
(7.37%)
46.20 1.15 
(2.55%)
16.85 - 58.47 611,867 465,679 7,943
02-11-2020 PM APLS Apellis Pharmaceuticals, Inc. 2,410 -1.79 -1.53 -1.10 Apellis Pharmaceuticals EPS misses by $0.21
[11/2/2020 7:14 AM]
36.95 3.48 
(10.40%)
33.47 0.0 
(0.00%)
16.85 - 45.04 983,650 547,945 11,746